EMA Considers EUA-Style Fast Track Decision For Molnupiravir
Article 5(3) Has Helped Speed Pandemic Response
The European Medicines Agency is considering making a rapid recommendation on MSD’s molnupiravir in order to speed access to the potential ‘game changer’ COVID-19 pill.
